pmid	doi	title	Hugo_Symbol
35953408	10.1016/j.humimm.2022.08.002	HLA homozygosity is associated with Non-Hodgkin lymphoma.	HLA-B
35759244	10.1002/iid3.666	EBV protection- and susceptibility-related HLA alleles and EBV status in the Chinese population: A single-center study.	HLA-B
35358442	10.1016/S2352-3026(22)00036-9	In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial.	HLA-B
34926267	10.3389/fonc.2021.765544	<i>SEPT6</i>_<i>TRIM33</i> Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas.	HLA-B
34925382	10.3389/fimmu.2021.796584	The HLA Ligandome Comprises a Limited Repertoire of O-GlcNAcylated Antigens Preferentially Associated With HLA-B*07:02.	HLA-B
34830986	10.3390/cancers13225833	HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients.	HLA-B
34717720	10.1186/s13045-021-01201-3	HLA alleles associated with asparaginase hypersensitivity in Chinese children.	HLA-B
34330762	10.1136/jitc-2021-002410	High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies.	HLA-B
33964277	10.1016/j.humpath.2021.04.014	Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma.	HLA-B
33899124	10.1007/s00894-021-04754-9	Deciphering the selective binding mechanisms of anaplastic lymphoma kinase-derived neuroblastoma tumor neoepitopes to human leukocyte antigen.	HLA-B
33747936	10.3389/fonc.2021.622648	Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.	HLA-B
33512416	10.1182/blood.2020007245	Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma.	HLA-B
32883310	10.1186/s12977-020-00536-y	HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.	HLA-B
32072624	10.1111/bjh.16398	Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda.	HLA-B
31958417	10.1016/S2352-3026(19)30220-0	Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.	HLA-B
31428523	10.1080/2162402X.2019.1625688	NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma.	HLA-B
31325731	10.1016/j.leukres.2019.106193	Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.	HLA-B
31215275	10.1080/10428194.2019.1617858	The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population.	HLA-B
31101215	10.1016/j.transproceed.2019.04.014	Non-Hodgkin Lymphoma in a Kidney Transplant Patient: A Case Report.	HLA-B
31066027	10.1002/cpt.1493	Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions.	HLA-B
31026237	10.1097/QAI.0000000000002027	Increasing Levels of Serum Heat Shock Protein 70 Precede the Development of AIDS-Defining Non-Hodgkin Lymphoma Among Carriers of HLA-B8-DR3.	HLA-B
30871628	10.1186/s40425-019-0538-8	Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab.	HLA-B
30715139	10.1093/asj/sjz021	Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.	HLA-B
30396848	10.1016/j.jcyt.2018.08.001	Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.	HLA-B
30032036	10.1016/j.neo.2018.07.001	Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma.	HLA-B
29735552	10.1158/0008-5472.CAN-17-2900	HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.	HLA-B
29441070	10.3389/fimmu.2018.00099	A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.	HLA-B
29147614	10.1080/2162402X.2017.1356964	Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy.	HLA-B
29080718	10.1016/j.humimm.2017.10.010	Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.	HLA-B
28981945	10.3760/cma.j.issn.1003-9406.2017.05.026	[Association of HLA-A, -B, -DRB1 alleles and haplotypes with acute lymphoblastic leukemia among ethnic Hans from northern China].	HLA-B
28980457	10.1111/tan.13151	The novel HLA-B*08:183 allele identified by sequence-based typing in a Caucasian leukemia patient.	HLA-B
28948342	10.1007/s00403-017-1783-7	Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients.	HLA-B
28811957	10.1080/2162402X.2017.1321184	Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma.	HLA-B
28659916	10.3389/fimmu.2017.00675	HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy.	HLA-B
28405493	10.1080/2162402X.2016.1219825	HLA class I-restricted <i>MYD88</i> L265P-derived peptides as specific targets for lymphoma immunotherapy.	HLA-B
28126967	10.3324/haematol.2016.158584	The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia.	HLA-B
28053195	10.1182/blood-2016-09-737536	TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1.	HLA-B
27987385	10.1016/j.bbmt.2016.11.021	MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study.	HLA-B
27776339	10.18632/oncotarget.12778	Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.	HLA-B
27696192	10.1007/s12185-016-2101-4	Fulminant type I diabetes mellitus associated with nivolumab in a patient with relapsed classical Hodgkin lymphoma.	HLA-B
27689397	10.18632/oncotarget.12247	A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer.	HLA-B
27602742	10.1038/537S60a	Pharmacogenetics: The right drug for you.	HLA-B
27273744	10.1111/tan.12829	The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.	HLA-B
27104753	10.3109/10428194.2016.1173209	Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder.	HLA-B
27095065	10.4274/tjh.2016.0102	The Frequency of HLA-A, HLA-B, and HLA-DRB1 Alleles in Patients with Acute Lymphoblastic Leukemia in the Turkish Population: A Case-Control Study.	HLA-B
27063556	10.1016/j.gene.2016.04.017	The associations of HLA-A, -B, DRB1 alleles and haplotypes in Turkish lymphoma patients.	HLA-B
26841353	10.1002/art.39515	Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.	HLA-B
26334430	10.1097/MPH.0000000000000419	HLA Polymorphism in Algerian Children With Lymphomas.	HLA-B
26189878	10.1111/tan.12604	Human leukocyte antigens and genetic susceptibility to lymphoma.	HLA-B
26040094		A coincidence of HLA-B27 negative spondyloarthritis and paravertebral non-Hodgkin's lymphoma--a lesson to be learnt from the past experience.	HLA-B
25753140	10.1111/jdv.13083	Mycosis fungoides: association of KIR ligands and HLA-DQB1*05 with bad prognosis of the disease.	HLA-B
25672859	10.5692/clinicalneurol.55.13	[Neuro-neutrophilic disease suspected by human leukocyte antigen (HLA) typing and brain biopsy: a case report].	HLA-B
25648508	10.1002/ijc.29467	Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.	HLA-B
25611436	10.1111/ejh.12513	Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations.	HLA-B
25569183	10.1038/ncomms6751	A genome-wide association study of marginal zone lymphoma shows association to the HLA region.	HLA-B
25549594	IJIv11i4A5	HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma.	HLA-B
25545232	10.1016/j.trim.2014.12.003	Donors with HLA-B*58:01/TNFα − 308A haplotype are unfavorable to haploidentical hematopoietic stem cell transplantation in acute lymphoblastic leukemia.	HLA-B
25414443	10.1182/blood-2014-07-587840	Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b.	HLA-B
25261932	10.1038/ng.3105	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	HLA-B
24963477	10.1155/2014/231236	The association of HLA-class I and class II with Hodgkin's lymphoma in Iranian patients.	HLA-B
24755352	10.1016/j.humimm.2014.04.004	Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma.	HLA-B
24533560	10.1111/jdv.12391	Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients.	HLA-B
24518758	10.1182/blood-2013-11-540625	The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia.	HLA-B
24364037	10.1155/2013/705862	HLA-B*40 allele plays a role in the development of acute leukemia in Mexican population: a case-control study.	HLA-B
24032727	10.1111/tan.12175	A novel HLA-B allele, HLA-B*39:01:16, identified by super high-resolution single-molecule sequence-based typing in a Japanese individual.	HLA-B
23843497	10.1182/blood-2013-02-483420	HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.	HLA-B
23376818	10.1038/bmt.2013.4	The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis.	HLA-B
23092091		[Incidence of uveitis in the northern Kyushu region of Japan --comparison between the periods of 1996-2001 and 2003-2008].	HLA-B
22781790		[The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].	HLA-B
22489945	10.1111/j.1399-0039.2012.01868.x	Somatic mutations in the HLA genes of patients with hematological malignancy.	HLA-B
22350167	10.1007/s00251-012-0605-5	Spectrum of HLA associations: the case of medically refractory pediatric acute lymphoblastic leukemia.	HLA-B
22340965	10.1016/S1470-2045(12)70004-9	Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.	HLA-B
22125456	10.1100/2011/373876	Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.	HLA-B
21982422	10.1016/S1470-2045(11)70260-1	Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.	HLA-B
21481192	10.1111/j.1744-313X.2011.01007.x	Detection of A B acute lymphoblastic leukaemia blast-specific mutation in HLA-B*39:01.	HLA-B
21059899	10.1182/blood-2010-08-301598	MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia.	HLA-B
21041953	10.1172/JCI42869	BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.	HLA-B
20870028	10.1016/j.bbmt.2010.09.012	HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.	HLA-B
20558104	10.1016/S1470-2045(10)70127-3	Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.	HLA-B
20522710	10.1182/blood-2010-02-270199	Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma.	HLA-B
20388056	10.3109/10428191003802340	Human leukocyte antigen class I alleles and the risk of chronic myelogenous leukemia: a meta-analysis.	HLA-B
20147981	10.1038/leu.2010.17	Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma.	HLA-B
20110857	10.1097/TP.0b013e3181c69855	Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation.	HLA-B
19654554	10.1097/QAI.0b013e3181b017d5	The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma.	HLA-B
19265139	10.4049/jimmunol.0802316	Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.	HLA-B
19235017	10.1080/10428190802668873	HLA risk markers for chronic myelogenous leukemia in Eastern Canada.	HLA-B
19167686	10.1016/j.bbmt.2008.11.025	Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.	HLA-B
19032105	10.1086/594373	The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children.	HLA-B
18841361	10.1007/s00262-008-0601-7	Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.	HLA-B
18724291	10.1038/bmt.2008.145	Current status of hematopoietic stem cell transplantations in Vietnam.	HLA-B
18587537	10.1007/s11060-008-9630-5	Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients.	HLA-B
18583252		[Association of HLA-A, B and DRB1 alleles with leukemia in Han population in Hunan Province].	HLA-B
18301962	10.1007/s12185-008-0040-4	Association of HLA alleles with non-Hodgkin's lymphoma in Korean population.	HLA-B
17971052	10.1111/j.1399-0039.2007.00954.x	Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.	HLA-B
17665074	10.1590/s0104-42302007000300024	[Association between HLA and leukemia in a mixed Brazilian population].	HLA-B
17589290	10.1097/CJI.0b013e3180336771	Cyclin-dependent kinaselike 5 is a novel target of immunotherapy in adult T-cell leukemia.	HLA-B
17560447	10.1016/S0140-6736(07)60915-5	Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.	HLA-B
17437273	10.1002/ijc.22767	Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types.	HLA-B
17311253	10.1002/gcc.20436	Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.	HLA-B
17302780	10.1111/j.1537-2995.2007.01109.x	A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.	HLA-B
17194665		Paraneoplastic stiff-person syndrome, heterotopic soft tissue ossification and gonarthritis in a HLA B27-positive woman preceding the diagnosis of Hodgkin's lymphoma.	HLA-B
17145860	10.1158/0008-5472.CAN-06-2326	Isolation of germ cells from leukemia and lymphoma cells in a human in vitro model: potential clinical application for restoring human fertility after anticancer therapy.	HLA-B
16933987	10.1371/journal.ppat.0020079	KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.	HLA-B
16710717	10.1007/s00277-006-0118-0	HLA-B67 may be a male-specific HLA marker of susceptibility to relapsed childhood ALL in Hong Kong Chinese and HLA-A33 or HLA-B17 signifies a higher presentation leukocytosis: A retrospective analysis on 53 transplant candidates (1989-2003).	HLA-B
16257267	10.1016/j.clim.2005.09.006	HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).	HLA-B
15916683	10.1111/j.1365-2141.2005.05499.x	Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings.	HLA-B
15854278		[Study on the correlation between acute lymphoblastic leukemia and HLA genes in southern China Han population].	HLA-B
15786697		Impact of standardization on clinical cell analysis by flow cytometry.	HLA-B
15731175	10.1182/blood-2004-12-4825	Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.	HLA-B
15621808	10.1080/10428190400013589	Two new cases of familial hairy cell leukemia associated with HLA haplotypes A2, B7, Bw4, Bw6.	HLA-B
14727382		[Association of HLA class I and leukemia in mestizo patients of the state of Zulia, Venezuela].	HLA-B
14634793	10.1007/s00277-003-0809-8	Decreased frequency of HLA-B35 in patients with gastric MALT lymphoma.	HLA-B
14515258	10.1002/eji.200324182	Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets.	HLA-B
13130260		[Characteristics of uveitis presenting de novo in the elderly].	HLA-B
12842998	10.1182/blood-2002-11-3584	Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapy.	HLA-B
12399966	10.1038/sj.leu.2402690	Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.	HLA-B
12352909	10.1097/00007890-200208270-00012	Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients.	HLA-B
12148880	10.1080/10428190290021588	Increased frequency of homozygosity for HLA class II loci in female patients with chronic lymphocytic leukemia.	HLA-B
12010826	10.1182/blood.v99.11.4200	The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.	HLA-B
11917131	10.1073/pnas.072495599	MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.	HLA-B
11872238	10.1016/s0198-8859(01)00381-0	Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon.	HLA-B
11869956		Keratoderma blenorrhagica, balanitis and uveitis after HLA-B15 mismatched bone marrow transplantation.	HLA-B
11485622	10.1089/088922201300343735	HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.	HLA-B
11169449	10.1002/1521-4141(200101)31:1&lt;156::aid-immu156&gt;3.0.co;2-p	Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries.	HLA-B
11122133		Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.	HLA-B
11035374	10.1038/sj.bmt.1702565	First manifestations of seronegative spondylarthropathy following autologous stem cell transplantation in HLA-B27-positive patients.	HLA-B
10717799	10.1016/s0198-8859(99)00147-0	Unrelated donors selected prospectively by block-matching have superior bone marrow transplant outcome.	HLA-B
10715516	10.1016/s0198-8859(99)00186-x	Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C.	HLA-B
10622558	10.1016/s0168-8278(99)80372-9	Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.	HLA-B
10566592	10.1016/s0198-8859(99)00076-2	Acquisition of a stimulatory activity for Vgamma9/Vdelta2 T cells by a Burkitt's lymphoma cell line without loss of HLA class I expression.	HLA-B
10026877	10.1007/978-1-4615-5357-1_36	Identification of epitopes for CTCL-specific cytotoxic T lymphocytes.	HLA-B
9892612	10.1084/jem.189.2.301	A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.	HLA-B
9780337	10.1056/NEJM199810223391701	Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.	HLA-B
9753343	10.1097/00007890-199809150-00013	Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.	HLA-B
9577643		[Post-transplant EBV-associated lymphoproliferative disorders--report of two cases].	HLA-B
9535555	10.1007/s001090050211	Immunotherapy of acute lymphoblastic leukemia by vaccination with autologous leukemic cells transfected with a cDNA expression plasmid coding for an allogeneic HLA class I antigen combined with interleukin-2 treatment.	HLA-B
9490691		Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia.	HLA-B
9508175	10.1200/JCO.1998.16.3.931	Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia.	HLA-B
9120290		Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.	HLA-B
9123502	10.1016/s0041-1345(96)00444-7	A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate.	HLA-B
8992968		Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.	HLA-B
7744880	10.1074/jbc.270.20.12276	The human leukocyte antigen A2 interferon-stimulated response element consensus sequence binds a nuclear factor required for constitutive expression.	HLA-B
7761977	10.1111/j.1399-0039.1995.tb02437.x	The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles.	HLA-B
8065158	10.1016/0145-2126(94)90037-x	Increased incidence of HLA antigen B35 in patients with chronic lymphocytic leukemia.	HLA-B
8107207	10.1128/JVI.68.3.1442-1448.1994	Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line.	HLA-B
8302299	10.1016/0161-5890(94)90138-4	Generation of HLA-B55 restricted T lymphocyte mediated cytotoxicity against autologous LCL.	HLA-B
7909466	10.3109/10428199409059592	Human major histocompatibility complex contains several leukemia susceptibility genes.	HLA-B
7820055		HLA typing in hairy cell leukemia.	HLA-B
8220228	10.1016/0248-4900(93)90117-w	Clinical applications of flow cytometry in hematology and immunology.	HLA-B
1285893	10.1111/j.1600-0897.1992.tb00806.x	Diffuse infiltrative lymphocytosis syndrome in children and adults infected with HIV-1: a model of rheumatic illness caused by acquired viral infection.	HLA-B
1738086		HLA-B35 is associated with accelerated progression to AIDS.	HLA-B
1899854	10.1002/ijc.2910470412	Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells.	HLA-B
1655115		Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.	HLA-B
2066181	10.1002/ijc.2910470703	Differential transcription inducibility by interferon of the HLA-A3 and HLA-B7 class-I genes.	HLA-B
2395381		Immunophenotypic and HLA studies in childhood acute lymphoblastic leukemia in Trinidad, West Indies.	HLA-B
2290171		Lymphoma presenting as a popliteal mass in a patient with rheumatoid arthritis.	HLA-B
2266272	10.1111/j.1744-313x.1990.tb00868.x	Altered expression of HLA-A,B specificities on acute lymphoid and myeloid leukaemia blasts.	HLA-B
2251046		[Histocompatibility antigens in children with acute lymphoblastic leukemia].	HLA-B
2804917	10.1002/1097-0142(19891201)64:11&lt;2259::aid-cncr2820641113&gt;3.0.co;2-0	Possible disorder of B-cell-related surveillance and malignant lymphoma of the thyroid.	HLA-B
2788584		Study of HLA antigens in patients with Hodgkin's disease.	HLA-B
2561749		[Cluster headache, Epstein-Barr and Burkitt's lymphoma virus infections].	HLA-B
2744385		[Class I and II HLA antigens in children with acute lymphoblastic leukemia].	HLA-B
2643045	10.1056/NEJM198901263200401	Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.	HLA-B
2535859		IFN-mediated differential regulation of the expression of HLA-B7 and HLA-A3 class I genes.	HLA-B
3199882		HLA-A11 is associated with poor prognosis in childhood acute lymphoblastic leukemia (ALL).	HLA-B
3131426		Isolation and nucleotide sequence of a cDNA clone encoding a novel HLA class I gene.	HLA-B
3259347		[Does the presence of HLA-B5 and B35 antigen signify a worse prognosis for Hodgkin's disease? Preliminary report].	HLA-B
2894907		HLA and adult T cell leukaemia: HLA-linked genes controlling susceptibility to human T cell leukaemia virus type I.	HLA-B
3092030	10.1016/0161-5890(86)90115-x	The synthesis and expression of HLA-A and -B antigens in Xenopus laevis oocytes.	HLA-B
2423453	10.3109/08820138609042018	Study on the association of HLA with malignant lymphoma.	HLA-B
3971646	10.1177/000992288502400315	Hodgkin's disease in siblings.	HLA-B
3872893	10.1016/s0190-9622(85)70075-8	Human leukocyte antigens in cutaneous T cell lymphoma.	HLA-B
2578520		Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens.	HLA-B
6390442	10.1073/pnas.81.23.7549	Recognition of HLA-A2 and -B7 antigens by cloned cytotoxic T lymphocytes after gene transfer into human and monkey, but not mouse, cells.	HLA-B
6334992	10.1097/00000441-198412000-00005	Graves' disease with ophthalmopathy following radiotherapy for Hodgkin's disease.	HLA-B
6376119	10.1002/j.1460-2075.1984.tb01915.x	Autogenous production of interferon-beta switches on HLA genes during differentiation of histiocytic lymphoma U937 cells.	HLA-B
6420131	10.1016/0011-5029(84)90005-1	Lymphocyte markers in health and disease.	HLA-B
6361126		Introduction of HLA-A/B antigens into lymphoid cell membranes by cell-liposome fusion.	HLA-B
6197461		Cytotoxic T lymphocyte recognition of HLA-A/B antigens introduced into EL4 cells by cell-liposome fusion.	HLA-B
6888550	10.1038/305060a0	Homology of human T-cell leukaemia virus envelope gene with class I HLA gene.	HLA-B
6888549	10.1038/305058a0	Cell lines producing human T-cell lymphoma virus show altered HLA expression.	HLA-B
6875280	10.1111/j.1744-313x.1983.tb00801.x	HLA in familial Hodgkin's disease.	HLA-B
6303316	10.1042/bj2100079	Human class I histocompatibility antigens (HLA-A,B,C). A small proportion only is phosphorylated.	HLA-B
6760459	10.1111/j.1399-0039.1982.tb02252.x	HLA typing in non-Hodgkin's lymphomas. Comparative study in Caucasoids, Mexican-Americans and Negroids.	HLA-B
6187075	10.1007/BF01543018	HLA antigen expression at the single cell level on a K562 X B cell hybrid: an analysis with monoclonal antibodies using bacterial binding assays.	HLA-B
6960462		[Detection of HLA-A, B and C antigens on various normal and pathologic cells using the monoclonal antibody W6/32].	HLA-B
6951167	10.1073/pnas.79.4.1190	Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression.	HLA-B
6181407		Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines.	HLA-B
7000762		Biosynthesis of HLA-A and HLA-B antigens in vivo.	HLA-B
32883310	10.1186/s12977-020-00536-y	HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.	HLA-B
24364037	10.1155/2013/705862	HLA-B*40 allele plays a role in the development of acute leukemia in Mexican population: a case-control study.	HLA-B
17493332		[Single nucleotide polymorphism in the promoter region of asparagine synthetase and its impact on the gene expression].	HLA-B
26841353	10.1002/art.39515	Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.	HLA-B
25549594	IJIv11i4A5	HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma.	HLA-B
25545232	10.1016/j.trim.2014.12.003	Donors with HLA-B*58:01/TNFα − 308A haplotype are unfavorable to haploidentical hematopoietic stem cell transplantation in acute lymphoblastic leukemia.	HLA-B
24755352	10.1016/j.humimm.2014.04.004	Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma.	HLA-B
22489945	10.1111/j.1399-0039.2012.01868.x	Somatic mutations in the HLA genes of patients with hematological malignancy.	HLA-B
20388056	10.3109/10428191003802340	Human leukocyte antigen class I alleles and the risk of chronic myelogenous leukemia: a meta-analysis.	HLA-B
11485622	10.1089/088922201300343735	HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.	HLA-B
7761977	10.1111/j.1399-0039.1995.tb02437.x	The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles.	HLA-B
27063556	10.1016/j.gene.2016.04.017	The associations of HLA-A, -B, DRB1 alleles and haplotypes in Turkish lymphoma patients.	HLA-B
24963477	10.1155/2014/231236	The association of HLA-class I and class II with Hodgkin's lymphoma in Iranian patients.	HLA-B
20536911	10.1111/j.1432-2277.2010.01117.x	Impact of amino acid substitution at residue 9 of HLA-A2 on the development of acute GVHD in Korean pediatric patients receiving unrelated hematopoietic stem cell transplantation.	HLA-B
19265139	10.4049/jimmunol.0802316	Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.	HLA-B
19199259	10.3760/cma.j.issn.1003-9406.2009.01.019	[Analysis of HLA haplotype frequency and linkage disequilibrium in patients with acute lymphoblastic leukemia from Northern Chinese Han].	HLA-B
18583252		[Association of HLA-A, B and DRB1 alleles with leukemia in Han population in Hunan Province].	HLA-B
17909631	10.1172/JCI32377	HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.	HLA-B
15854278		[Study on the correlation between acute lymphoblastic leukemia and HLA genes in southern China Han population].	HLA-B
14727382		[Association of HLA class I and leukemia in mestizo patients of the state of Zulia, Venezuela].	HLA-B
10715516	10.1016/s0198-8859(99)00186-x	Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C.	HLA-B
2450918		Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin.	HLA-B
20385791	10.1182/blood-2010-01-266775	Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.	HLA-B
20147981	10.1038/leu.2010.17	Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma.	HLA-B
19654554	10.1097/QAI.0b013e3181b017d5	The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma.	HLA-B
17437273	10.1002/ijc.22767	Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types.	HLA-B
26472014	10.1016/j.humimm.2015.10.009	Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.	HLA-B
18301962	10.1007/s12185-008-0040-4	Association of HLA alleles with non-Hodgkin's lymphoma in Korean population.	HLA-B
12010826	10.1182/blood.v99.11.4200	The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.	HLA-B
21059899	10.1182/blood-2010-08-301598	MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia.	HLA-B
19235017	10.1080/10428190802668873	HLA risk markers for chronic myelogenous leukemia in Eastern Canada.	HLA-B
18544086	10.1111/j.1365-2141.2008.07177.x	Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.	HLA-B
17971052	10.1111/j.1399-0039.2007.00954.x	Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.	HLA-B
17311253	10.1002/gcc.20436	Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.	HLA-B
15202948	10.1186/1471-2407-4-25	Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).	HLA-B
23326239	10.1371/journal.pgen.1003147	A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).	HLA-B
18005680	10.1016/j.chom.2007.01.001	A two-pronged mechanism for HIV-1 Nef-mediated endocytosis of immune costimulatory molecules CD80 and CD86.	HLA-B
25261932	10.1038/ng.3105	Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.	HLA-B
19493232	10.1111/j.1399-0039.2009.01235.x	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	HLA-B
